| You searched for pathology |
Results 1 to 14 of 21 |
Page 1  |
- Pathophysiology - 46.1%
... apathy, psychosis, cognitive impairments, restlessness, face flushing, sweating, increased salivation and sleep disorders. [ 4 , 5 ] The primary pathology of PD is the death of dopaminergic neurons in the substantia nigra and the nigrostriatal pathway of the midbrain (Figure 1), with Lewy bodies ...
Click here to view page
- Non-Small Cell Lung Cancer (NSCLC) - 46.1%
... Centre What’s in the Non-Small Cell Lung Cancer (NSCLC) Knowledge Centre? Home Non-small Cell Lung Cancer Causes Risk Factors Histology/Pathology Disease Staging/Prognosis TNM Systems Factors that affect prognosis Signs and Symptoms Diagnosis Early Stage disease (stage I, II, IIIA) Treatment ...
Click here to view page
- Histology/Pathology - 46.1%
Non-small Cell Lung Cancer Histology/Pathology Small Cell Lung Cancer (SCLC) The SCLCs account for 20% of lung tumours (figure 1); they are usually centrally located and are relatively sensitive to cytotoxic chemotherapy. 1 Clinically, they are associated with relatively rapid tumour growth and ...
Click here to view page
- About LSD's - 46.1%
... this a disease group likely to be encountered in many medical practices. Delayed diagnosis is the greatest roadblock to optimal care Skeletal pathology is highly prevalent among patients with lysosomal storage disorders however, due to the wide variability of symptom presentation and lack of disease ...
Click here to view page
- Opioids - 46.1%
... of administration. The choice of opioid will depend on a number of factors such as route of administration, duration of onset, patient pathology and any concomitant medication, physician preference and familiarity, patient preference, availability, accessibility, cost, previous analgesic ...
Click here to view page
- Lutein Supplementation - 46.1%
Lutein Supplementation Lutein supplementation – the potential to intervene on AMD pathology Carotenoid intake has shown to reduce the risk of severe AMD – thus demonstrating a clear link between dietary supplementation and disease management 7 1. Taylor HR, et al. The Long-term Effects of Visible ...
Click here to view page
- GIST - 41.9%
... immunohistochemical analysis of several markers, including KIT. Equivocal cases should be submitted to a central review by an expert in sarcoma pathology, experienced in the diagnosis of GIST. Before the availability of Glivec, the only treatments for GIST other than surgery were conventional ...
Click here to view page
- Lysosomal storage disorders (LSDs) - 41.9%
... in many medical practices. Lysosomal storage disorders include Gaucher disease , MPS1 disease , Fabry disease and Pompe disease . Skeletal pathology is highly prevalent among patients with lysosomal storage disorders however, due to the wide variability of symptom presentation and lack of disease ...
Click here to view page
- Alzheimer’s Disease - 41.9%
... memory loss, disorientation and confusion. These symptoms are caused by the loss of neurons and worsen with continuous neurodegeneration. The pathology of dementia is not solely the result of a cholinergic deficit. It is known that, chronically and pathologically elevated glutamate concentrations ...
Click here to view page
- Diagnosis- Immunohistochemistry - 41.9%
... harbour mutations in the PDGFRA gene. 5 References: 1. Miettinen M, Lasota J. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol. 2003;54:3-24. 2. Demetri G, Benjamin R, Blanke CD, et al. NCCN Task Force report ...
Click here to view page
- Diagnosis- Histopathology - 41.9%
... appearance of the tumour can vary throughout a single mass and can change with therapy. 1 Fixed tissue samples are evaluated in the surgical pathology laboratory, by light microscopic examination after thin sectioning and staining with a general morphological stain such as haematoxylin and eosin ...
Click here to view page
- Differential Diagnosis - 41.9%
... tumours: an update. Histopathology. 2006;48:83-96. 3. Miettinen M, Lasota J. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol. 2003;54:3-24. 4. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum ...
Click here to view page
- Diagnosis - 41.9%
... immunohistochemical analysis of several markers, including KIT. Equivocal cases should be submitted to a central review by an expert in sarcoma pathology, experienced in the diagnosis of GIST. 1 References: 1. Blay JY, Bonvalot S, Casali P, et al. Consensus meeting for the management of ...
Click here to view page
- Triptans - 41.9%
... of migraine therapy when discovered. Triptans represent the first class of drugs designed to relieve migraine symptoms by targeting the disease pathology. Unlike non-specific medications that increase patients’ tolerance to pain, nausea and associated symptoms, triptans act specifically via ...
Click here to view page
|
|
Medical News
